217 related articles for article (PubMed ID: 37823593)
1. PML modulates epigenetic composition of chromatin to regulate expression of pro-metastatic genes in triple-negative breast cancer.
Fracassi C; Ugge' M; Abdelhalim M; Zapparoli E; Simoni M; Magliulo D; Mazza D; Lazarevic D; Morelli MJ; Collas P; Bernardi R
Nucleic Acids Res; 2023 Nov; 51(20):11024-11039. PubMed ID: 37823593
[TBL] [Abstract][Full Text] [Related]
2. PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes.
Ponente M; Campanini L; Cuttano R; Piunti A; Delledonne GA; Coltella N; Valsecchi R; Villa A; Cavallaro U; Pattini L; Doglioni C; Bernardi R
JCI Insight; 2017 Feb; 2(4):e87380. PubMed ID: 28239645
[TBL] [Abstract][Full Text] [Related]
3. PML nuclear bodies as sites of epigenetic regulation.
Torok D; Ching RW; Bazett-Jones DP
Front Biosci (Landmark Ed); 2009 Jan; 14(4):1325-36. PubMed ID: 19273133
[TBL] [Abstract][Full Text] [Related]
4. Modulation of H3.3 chromatin assembly by PML: A way to regulate epigenetic inheritance.
Delbarre E; Janicki SM
Bioessays; 2021 Oct; 43(10):e2100038. PubMed ID: 34423467
[TBL] [Abstract][Full Text] [Related]
5. PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX.
Delbarre E; Ivanauskiene K; Spirkoski J; Shah A; Vekterud K; Moskaug JØ; Bøe SO; Wong LH; Küntziger T; Collas P
Genome Res; 2017 Jun; 27(6):913-921. PubMed ID: 28341773
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of TRIM33 to cell-context specific PML nuclear bodies regulates nodal signaling in mESCs.
Sun H; Chen Y; Yan K; Shao Y; Zhang QC; Lin Y; Xi Q
EMBO J; 2023 Feb; 42(3):e112058. PubMed ID: 36524443
[TBL] [Abstract][Full Text] [Related]
7. Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis.
Cohen C; Corpet A; Roubille S; Maroui MA; Poccardi N; Rousseau A; Kleijwegt C; Binda O; Texier P; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2018 Sep; 14(9):e1007313. PubMed ID: 30235352
[TBL] [Abstract][Full Text] [Related]
8. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.
Cao T; Duprez E; Borden KL; Freemont PS; Etkin LD
J Cell Sci; 1998 May; 111 ( Pt 10)():1319-29. PubMed ID: 9570750
[TBL] [Abstract][Full Text] [Related]
9. PML nuclear bodies and chromatin dynamics: catch me if you can!
Corpet A; Kleijwegt C; Roubille S; Juillard F; Jacquet K; Texier P; Lomonte P
Nucleic Acids Res; 2020 Dec; 48(21):11890-11912. PubMed ID: 33068409
[TBL] [Abstract][Full Text] [Related]
10. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic Leukemia (PML) gene regulation: implication towards curbing oncogenesis.
Datta N; Islam S; Chatterjee U; Chatterjee S; Panda CK; Ghosh MK
Cell Death Dis; 2019 Sep; 10(9):656. PubMed ID: 31506431
[TBL] [Abstract][Full Text] [Related]
12. Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres.
Salsman J; Rapkin LM; Margam NN; Duncan R; Bazett-Jones DP; Dellaire G
Cell Death Dis; 2017 Mar; 8(3):e2724. PubMed ID: 28358373
[TBL] [Abstract][Full Text] [Related]
13. PML-associated repressor of transcription (PAROT), a novel KRAB-zinc finger repressor, is regulated through association with PML nuclear bodies.
Fleischer S; Wiemann S; Will H; Hofmann TG
Exp Cell Res; 2006 Apr; 312(6):901-12. PubMed ID: 16412420
[TBL] [Abstract][Full Text] [Related]
14. PML isoforms: a molecular basis for PML pleiotropic functions.
Uggè M; Simoni M; Fracassi C; Bernardi R
Trends Biochem Sci; 2022 Jul; 47(7):609-619. PubMed ID: 35232626
[TBL] [Abstract][Full Text] [Related]
15. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
[TBL] [Abstract][Full Text] [Related]
16. TTRAP is a novel PML nuclear bodies-associated protein.
Xu GL; Pan YK; Wang BY; Huang L; Tian L; Xue JL; Chen JZ; Jia W
Biochem Biophys Res Commun; 2008 Oct; 375(3):395-8. PubMed ID: 18706885
[TBL] [Abstract][Full Text] [Related]
17. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
Jiang M; Entezami P; Gamez M; Stamminger T; Imperiale MJ
mBio; 2011; 2(1):e00281-10. PubMed ID: 21304169
[TBL] [Abstract][Full Text] [Related]
18. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
Reineke EL; Kao HY
Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
[TBL] [Abstract][Full Text] [Related]
19. Patient mutations alter ATRX targeting to PML nuclear bodies.
Bérubé NG; Healy J; Medina CF; Wu S; Hodgson T; Jagla M; Picketts DJ
Eur J Hum Genet; 2008 Feb; 16(2):192-201. PubMed ID: 17957225
[TBL] [Abstract][Full Text] [Related]
20. LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies.
Dent AL; Yewdell J; Puvion-Dutilleul F; Koken MH; de The H; Staudt LM
Blood; 1996 Aug; 88(4):1423-6. PubMed ID: 8695863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
